Literature DB >> 28058576

Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace.

Chih-Lin Lin1,2, Jia-Horng Kao3,4,5,6.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28058576     DOI： 10.1007/s12072-016-9782-x

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  24 in total

Review 1.  Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.

Authors:  Winnie Yeo; Philip J Johnson
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

2.  Prevention of acute exacerbation of chronic hepatitis B infection in cancer patients receiving chemotherapy in a hepatitis B virus endemic area.

Authors:  Ping-I Hsu; Kwok-Hung Lai; Jin-Shiung Cheng; Sung-Shuo Kao; Yuan-Rung Li; Wei-Chih Sun; Wen-Chi Chen; Kung-Hung Lin; Chih-An Shin; Po-Hung Chiang; Yun-Da Li; Wei-Ting Ou; Hui-Chun Chen; Hsien-Chung Yu
Journal:  Hepatology       Date:  2015-06-03       Impact factor: 17.425

3.  Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2011-06-14       Impact factor: 6.047

4.  Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load.

Authors:  Tatsuji Kimura; Akinori Rokuhara; Yoko Sakamoto; Shintaro Yagi; Eiji Tanaka; Kendo Kiyosawa; Noboru Maki
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.

Authors:  C Loras; J P Gisbert; M Mínguez; O Merino; L Bujanda; C Saro; E Domenech; J Barrio; M Andreu; I Ordás; L Vida; G Bastida; F González-Huix; M Piqueras; D Ginard; X Calvet; A Gutiérrez; A Abad; M Torres; J Panés; M Chaparro; I Pascual; M Rodriguez-Carballeira; F Fernández-Bañares; J M Viver; M Esteve
Journal:  Gut       Date:  2010-06-24       Impact factor: 23.059

Review 6.  Global control of hepatitis B virus infection.

Authors:  Jia-Horng Kao; Ding-Shinn Chen
Journal:  Lancet Infect Dis       Date:  2002-07       Impact factor: 25.071

Review 7.  Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.

Authors:  Rohit Loomba; Ayana Rowley; Robert Wesley; T Jake Liang; Jay H Hoofnagle; Frank Pucino; Gyorgy Csako
Journal:  Ann Intern Med       Date:  2008-04-01       Impact factor: 25.391

8.  Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.

Authors:  Wai-Kay Seto; Thomas S Y Chan; Yu-Yan Hwang; Danny Ka-Ho Wong; James Fung; Kevin Sze-Hang Liu; Harinder Gill; Yuk-Fai Lam; Albert K W Lie; Ching-Lung Lai; Yok-Lam Kwong; Man-Fung Yuen
Journal:  J Clin Oncol       Date:  2014-10-06       Impact factor: 44.544

9.  Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients.

Authors:  Liang-Tsai Hsiao; Hao-Yuan Wang; Ching-Fen Yang; Tzeon-Jye Chiou; Jyh-Pyng Gau; Yuan-Bin Yu; Hsiao-Ling Liu; Wen-Chun Chang; Po-Min Chen; Cheng-Hwai Tzeng; Yu-Jiun Chan; Muh-Hwa Yang; Jin-Hwang Liu; Yi-Hsiang Huang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 10.  New perspectives of biomarkers for the management of chronic hepatitis B.

Authors:  Chih-Lin Lin; Jia-Horng Kao
Journal:  Clin Mol Hepatol       Date:  2016-12-25
View more
  2 in total

1.  A Rare Case of Pembrolizumab-Induced Reactivation of Hepatitis B.

Authors:  Anita Pandey; Susan Ezemenari; Maksim Liaukovich; Ivan Richard; Avezbakiyev Boris
Journal:  Case Rep Oncol Med       Date:  2018-10-17

2.  APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation.

Authors:  Tatsuo Kanda; George K K Lau; Lai Wei; Mitsuhiko Moriyama; Ming-Lung Yu; Wang-Long Chuang; Alaaeldin Ibrahim; Cosmas Rinaldi Adithya Lesmana; Jose Sollano; Manoj Kumar; Ankur Jindal; Barjesh Chander Sharma; Saeed S Hamid; A Kadir Dokmeci; Geoffrey W McCaughan; Jafri Wasim; Darrell H G Crawford; Jia-Horng Kao; Yoshihiko Ooka; Osamu Yokosuka; Shiv Kumar Sarin; Masao Omata
Journal:  Hepatol Int       Date:  2019-09-20       Impact factor: 6.047
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.